Search

David J. Blanchard

Examiner (ID: 10564)

Most Active Art Unit
1643
Art Unit(s)
1643, 1642, 1619
Total Applications
552
Issued Applications
169
Pending Applications
113
Abandoned Applications
273

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5826965 [patent_doc_number] => 20060062786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Antibodies that immunospecifically bind to TRAIL receptors' [patent_app_type] => utility [patent_app_number] => 11/221281 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 192046 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20060062786.pdf [firstpage_image] =>[orig_patent_app_number] => 11221281 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/221281
Antibodies that immunospecifically bind to TRAIL receptors Sep 7, 2005 Abandoned
Array ( [id] => 5742814 [patent_doc_number] => 20060088539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Modified antibodies to prostate-specific membrane antigen and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/219563 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 88733 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088539.pdf [firstpage_image] =>[orig_patent_app_number] => 11219563 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/219563
Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen Sep 1, 2005 Issued
Array ( [id] => 5827016 [patent_doc_number] => 20060062793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Modified antibodies to prostate-specific membrane antigen and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/218813 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 87985 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20060062793.pdf [firstpage_image] =>[orig_patent_app_number] => 11218813 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/218813
Modified antibodies to prostate-specific membrane antigen and uses thereof Sep 1, 2005 Abandoned
Array ( [id] => 4999346 [patent_doc_number] => 20070041980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'CA6 antigen-specific cytotoxic conjugate and methods of using the same' [patent_app_type] => utility [patent_app_number] => 11/213046 [patent_app_country] => US [patent_app_date] => 2005-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 27534 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20070041980.pdf [firstpage_image] =>[orig_patent_app_number] => 11213046 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/213046
CA6 antigen-specific cytotoxic conjugate and methods of using the same Aug 28, 2005 Issued
Array ( [id] => 5766776 [patent_doc_number] => 20060018900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Self antigen vaccines for treating B-cell lymphomas and other cancers' [patent_app_type] => utility [patent_app_number] => 11/209592 [patent_app_country] => US [patent_app_date] => 2005-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26893 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018900.pdf [firstpage_image] =>[orig_patent_app_number] => 11209592 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/209592
Self antigen vaccines for treating B-cell lymphomas and other cancers Aug 21, 2005 Abandoned
Array ( [id] => 330626 [patent_doc_number] => 07511122 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-31 [patent_title] => 'Humanized and chimeric antibodies specific for lipoteichoic acid of GRAM positive bacteria' [patent_app_type] => utility [patent_app_number] => 11/193440 [patent_app_country] => US [patent_app_date] => 2005-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 16697 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/511/07511122.pdf [firstpage_image] =>[orig_patent_app_number] => 11193440 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/193440
Humanized and chimeric antibodies specific for lipoteichoic acid of GRAM positive bacteria Jul 31, 2005 Issued
Array ( [id] => 459382 [patent_doc_number] => 07237491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Variable function person transportation system(s)' [patent_app_type] => utility [patent_app_number] => 11/193404 [patent_app_country] => US [patent_app_date] => 2005-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 39 [patent_no_of_words] => 11764 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/237/07237491.pdf [firstpage_image] =>[orig_patent_app_number] => 11193404 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/193404
Variable function person transportation system(s) Jul 31, 2005 Issued
Array ( [id] => 5819987 [patent_doc_number] => 20060024300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Immunoglobulin variants and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/190364 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 37303 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024300.pdf [firstpage_image] =>[orig_patent_app_number] => 11190364 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/190364
Immunoglobulin variants and uses thereof Jul 25, 2005 Abandoned
Array ( [id] => 5769162 [patent_doc_number] => 20060019923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Methods and compositions for inducing innate immune responses' [patent_app_type] => utility [patent_app_number] => 11/184065 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22383 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019923.pdf [firstpage_image] =>[orig_patent_app_number] => 11184065 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/184065
Methods and compositions for inducing innate immune responses Jul 17, 2005 Abandoned
Array ( [id] => 5769162 [patent_doc_number] => 20060019923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Methods and compositions for inducing innate immune responses' [patent_app_type] => utility [patent_app_number] => 11/184065 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22383 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019923.pdf [firstpage_image] =>[orig_patent_app_number] => 11184065 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/184065
Methods and compositions for inducing innate immune responses Jul 17, 2005 Abandoned
Array ( [id] => 318832 [patent_doc_number] => 07521542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Humanized FcγRIIB-specific antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/126978 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 62737 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521542.pdf [firstpage_image] =>[orig_patent_app_number] => 11126978 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/126978
Humanized FcγRIIB-specific antibodies and methods of use thereof May 9, 2005 Issued
Array ( [id] => 5246962 [patent_doc_number] => 20070243196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Mage-3 and NY-ESO-1 Based Polyvalent Vaccine for Cancer Immunotherapy' [patent_app_type] => utility [patent_app_number] => 11/568566 [patent_app_country] => US [patent_app_date] => 2005-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5079 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243196.pdf [firstpage_image] =>[orig_patent_app_number] => 11568566 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/568566
Mage-3 and NY-ESO-1 Based Polyvalent Vaccine for Cancer Immunotherapy May 1, 2005 Abandoned
Array ( [id] => 263909 [patent_doc_number] => 07569674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Autophilic antibodies' [patent_app_type] => utility [patent_app_number] => 11/119404 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12022 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569674.pdf [firstpage_image] =>[orig_patent_app_number] => 11119404 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/119404
Autophilic antibodies Apr 28, 2005 Issued
Array ( [id] => 7243643 [patent_doc_number] => 20050271670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Treatments for cancer' [patent_app_type] => utility [patent_app_number] => 11/119309 [patent_app_country] => US [patent_app_date] => 2005-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9516 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271670.pdf [firstpage_image] =>[orig_patent_app_number] => 11119309 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/119309
Treatments for cancer Apr 27, 2005 Abandoned
Array ( [id] => 5894883 [patent_doc_number] => 20060003422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Method for the identification of substances mimicking mammal epitopes' [patent_app_type] => utility [patent_app_number] => 11/108888 [patent_app_country] => US [patent_app_date] => 2005-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5519 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003422.pdf [firstpage_image] =>[orig_patent_app_number] => 11108888 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/108888
Method for the identification of substances mimicking mammal epitopes Apr 18, 2005 Abandoned
Array ( [id] => 6945265 [patent_doc_number] => 20050197314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines' [patent_app_type] => utility [patent_app_number] => 11/110189 [patent_app_country] => US [patent_app_date] => 2005-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21784 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197314.pdf [firstpage_image] =>[orig_patent_app_number] => 11110189 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/110189
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines Apr 18, 2005 Abandoned
Array ( [id] => 7247517 [patent_doc_number] => 20050272120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor' [patent_app_type] => utility [patent_app_number] => 11/102501 [patent_app_country] => US [patent_app_date] => 2005-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 65981 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272120.pdf [firstpage_image] =>[orig_patent_app_number] => 11102501 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/102501
Compositions and methods for the diagnosis and treatment of tumor Apr 7, 2005 Abandoned
Array ( [id] => 7182910 [patent_doc_number] => 20050191313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Vaccine and immunotherapy for solid nonlymphoid tumor and related immune dysregulation' [patent_app_type] => utility [patent_app_number] => 11/097873 [patent_app_country] => US [patent_app_date] => 2005-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18897 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191313.pdf [firstpage_image] =>[orig_patent_app_number] => 11097873 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/097873
Vaccine and immunotherapy for solid nonlymphoid tumor and related immune dysregulation Mar 31, 2005 Abandoned
Array ( [id] => 5880515 [patent_doc_number] => 20060029597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'IgA antibody protein as a cytotoxic drug' [patent_app_type] => utility [patent_app_number] => 11/094302 [patent_app_country] => US [patent_app_date] => 2005-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7805 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029597.pdf [firstpage_image] =>[orig_patent_app_number] => 11094302 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/094302
IgA antibody protein as a cytotoxic drug Mar 30, 2005 Abandoned
Array ( [id] => 5230239 [patent_doc_number] => 20070292346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk' [patent_app_type] => utility [patent_app_number] => 10/593799 [patent_app_country] => US [patent_app_date] => 2005-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 41401 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20070292346.pdf [firstpage_image] =>[orig_patent_app_number] => 10593799 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/593799
Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk Mar 24, 2005 Abandoned
Menu